Chinese and Western Medicine Treatment of Fever Associated With Bleeding Symptoms

Brief Title

Chinese and Western Medicine Treatment of Fever Associated With Bleeding Symptoms

Official Title

Syndrome of Fever Associated With Bleeding of Chinese and Western Medicine Diagnosis and Treatment of Infectious Diseases Plans and Severe Clinical Treatment Research

Brief Summary

      To meet eligibility criteria, this study and informed consent of the syndrome of fever
      associated with bleeding of infectious diseases, severe patients to carry out multicenter,
      practical randomized controlled clinical research, to compare the curative effect of western
      medicine, combining Chinese and western medicine treatment, and security, and pathogenesis of
      TCM and syndrome, severe immune related factor and syndrome type of traditional Chinese
      medicine, Chinese medicine prescriptions mechanism research.
    

Detailed Description

      Randomized method: using large sample, central randomized, parallel comparison of Chinese and
      western medicine and western medicine group.
    

Study Phase

Phase 2

Study Type

Interventional


Primary Outcome

Mortality

Secondary Outcome

 Safety outcome

Condition

Viral Haemorrhagic Fever

Intervention

Western Medicine

Study Arms / Comparison Groups

 TCM and Western Medicine
Description:  TCM and Western Medicine:First Infectious diseases soup recipe,every time a dose,Two times a day;Ribavirin 10-15mg per kg every time Western Medicine:Ribavirin 10-15mg per kg every time

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information


Recruitment Status

Drug

Estimated Enrollment

300

Start Date

January 2012

Completion Date

December 2015

Primary Completion Date

March 2015

Eligibility Criteria

        Inclusion Criteria:

          -  Viral diseases, such as dengue fever, kidney of hemorrhagic fever, such as xinjiang
             hemorrhagic fever; Or clinical has fever associated with bleeding as the main
             performance, and confirmed as the new emergent infectious diseases

        Exclusion Criteria:

          -  Diagnosed with flu, hand, foot and mouth disease, viral hepatitis (except the
             carrier), liver cirrhosis after hepatitis, AIDS, rabies, encephalitis, polio, measles,
             German measles, chickenpox, herpes, infectious mononucleosis, infectious atypical
             pneumonia
      

Gender

All

Ages

18 Years - 65 Years

Accepts Healthy Volunteers

No

Contacts

Tan X Hua, 13500039656, [email protected]

Location Countries

China

Location Countries

China

Administrative Informations


NCT ID

NCT01973855

Organization ID

2012ZX10004301-003


Responsible Party

Principal Investigator

Study Sponsor

Guangzhou 8th People's Hospital


Study Sponsor

Tan X Hua, Study Director, Guangzhou 8th hospitol


Verification Date

October 2013